Korean Biopharma IPOs Start Strong With Prestige
Investors Await Big SK Bioscience Listing
Following a successful offering by Prestige BioPharma in January, investors will keep their focus on another upcoming major listing by the SK Group's specialist vaccines arm SK Bioscience, which is likely to set the tone for the South Korean biopharma IPO market this year.
